-
Development of potent PLA2 inhibitors to target PRDX6, a novel host based malaria drug target Position A 2-year postdoctoral position is available in the Unité de Biologie de Plasmodium et Vaccins
-
proteins evolve and on designing broad‑acting antigens as potential vaccine targets. The experimental branch of the lab validates computational predictions through serology, protein stability assays, and
-
immunotherapy interventions targeting CD4+ T cells based on recombinant monoclonal antibodies or mRNA-containing lipid nanoparticles. The project will be primarily developed in a pre-clinical murine model of lung
-
biological mechanisms that could constitute relevant targets for new treatments. We are leading the genetic work package of AIMS-2-TRIALS, the largest European project on autism research. The project is
-
mechanisms that could constitute relevant targets for new treatments. We are leading the genetic work package of AIMS-2-TRIALS, the largest European project on autism research. The project is focused on deep